Pegylated liposomal doxorubicin (PLD) in daily practice – A single center experience of treatment with PLD in elderly and co-morbid patients with metastatic breast cancer. (October 2022) - Wallrabenstein, T.; Daetwyler, E.S.; Oseledchyk, A.; Rochlitz, C.; Vetter, M.